Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln | |||||
14:45 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 26 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
Fr | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 402 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
19.09. | Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom | 1 | Cision News | ||
10.09. | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 65 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
25.08. | Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership | 2 | Cision News | ||
20.08. | Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide | 2 | Cision News | ||
12.08. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 112 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen | |
29.07. | Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth | 2 | Cision News | ||
27.07. | Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK | 2 | Cision News | ||
25.07. | (RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
24.07. | Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation | 1 | Cision News | ||
01.07. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025 | 133 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division proudly announces record-breaking sales in the second quarter of 2025. With continued momentum from a strong start to the quarter, the team achieved... ► Artikel lesen | |
06.05. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025 | 128 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Interim Report for Q1 2025.
First-quarter sales reached 2 472 KSEK, which is the best quarter so far. All sales originated from Animal Care.
First... ► Artikel lesen | |
04.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024 | 143 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) hereby publishes the Year-End Report for 2024.
Fourth-quarter sales reached 2 041 KSEK, which is the best quarter in 2024. Total annual sales amounted to 6 566 KSEK-entirely... ► Artikel lesen | |
30.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months | 200 | GlobeNewswire (Europe) | ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a 2.4 MSEK loan from two external investors... ► Artikel lesen | |
24.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care operations showed positive cashflow for 2024 in separate reporting | 204 | GlobeNewswire (Europe) | Scandinavian ChemoTech is pleased to announce that our Animal Care operations would already be showing a positive cash flow if we reported our business areas separately. This underscores the importance... ► Artikel lesen | |
09.01. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues | 167 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB, in line with the structural changes for the group published on December 30, 2024, has decided to implement measures aimed at achieving financial sustainability. As part of... ► Artikel lesen | |
30.12.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group | 220 | GlobeNewswire (Europe) | Since 2021, Scandinavian ChemoTech has operated two distinct business units - Human Care and Animal Care. While Human Care was the group's initial focus, the Board of Directors has made key decisions... ► Artikel lesen | |
29.11.24 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care division is heading for a strong fourth quarter 2024 in terms of sales | 141 | GlobeNewswire (Europe) | Animal Care is on track to close 2024 on a high note, with sales in the fourth quarter already reaching approximately 1,500 KSEK and projected to surpass 6,000 KSEK for the full year. This highlights... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 46,300 | +0,61 % | Hohe Investitionen und Strafen - SAP, Siemens, Siemens Healthineers, Vidac Pharma | Langsam zeichnet sich eine Erholung in der Robotik-Branche ab, nachdem die Umsätze über lange Zeit stagnierten. Dennoch spüren die europäischen Roboter-Hersteller den Druck aus China, die nun auch nach... ► Artikel lesen | |
FRESENIUS | 47,400 | 0,00 % | Kandidat für das "Zertifikat des Jahres": DZ BANK-Best of Basket ST 25/30 auf Allianz, Fresenius, SocGen | Schwarzach am Main (www.anleihencheck.de) - Am 13. November zeichnet Der Zertifikateberater gemeinsam mit ntv, Finanzen.net, onvista, der stock3 AG sowie dem Hauptsponsor gettex zum bereits 24. Mal... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,280 | +1,39 % | Fresenius Medical Care: War das die Trendwende? | ||
CARL ZEISS MEDITEC | 43,440 | +3,04 % | Carl Zeiss Meditec-Aktie: Das tut weh! | Die Aktie von Carl Zeiss Meditec hatte sich zuletzt etwas erholen können. Nun gibt es den nächsten Abverkauf. Hören die schlechten Zeiten für Aktionäre denn nie auf? USA als Belastungsfaktor Die Aktien... ► Artikel lesen | |
GERRESHEIMER | 36,940 | +4,65 % | EQS-News: Gerresheimer AG: Gerresheimer nimmt Stellung zur Prüfung durch die BaFin | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges
Gerresheimer nimmt Stellung zur Prüfung durch die BaFin
24.09.2025 / 10:48 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
UNITEDHEALTH | 291,55 | -0,90 % | HeraMED beschleunigt seinen KI-Fahrplan - Die nächste Phase der Frauengesundheit beginnt jetzt | ||
ECKERT & ZIEGLER | 17,710 | -0,62 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 24 Euro auf "Buy" belassen. Unternehmenschef Harald Hasselmann habe seine positive... ► Artikel lesen | |
THERMO FISHER | 447,30 | +8,28 % | Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub | The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,360 | -6,35 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 29,585 | -0,02 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
HIMS & HERS HEALTH | 48,850 | +1,14 % | BofA Securities maintains Underperform rating on Hims and Hers stock | ||
STRATEC | 30,350 | +5,93 % | STRATEC SE explodiert - jetzt nicht zögern! | ||
HEARTFLOW | 35,410 | +5,32 % | HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis | ||
GENEDX | 113,21 | +5,00 % | GeneDx Appoints Lisa Gurry as Chief Business Officer | ||
DRAEGERWERK | 65,00 | +2,69 % | Drägerwerk: Experten nehmen Gewinnschätzungen zurück | Im Bereich der Medizintechnik kommt Drägerwerk im ersten Halbjahr beim Auftragseingang auf ein Plus von 15 Prozent. Das dürfte sich im zweiten Halbjahr positiv beim Ergebnis bemerkbar machen. Belastend... ► Artikel lesen |